JAK-STAT Signaling Pathway Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for JAK-STAT Signaling Pathway. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
JAK-STAT Signaling Pathway Indian Medical PG Question 1: Gene not involved in SCID:
- A. BTK (Correct Answer)
- B. ZAP70
- C. IL2RG
- D. JAK3
JAK-STAT Signaling Pathway Explanation: ***BTK***
- **Bruton's tyrosine kinase (BTK)** is associated with **X-linked agammaglobulinemia (XLA)**, a primary immunodeficiency characterized by the absence of mature B cells and significantly reduced antibody production. While it causes severe immune deficiency, it is not a direct cause of **SCID**.
- XLA results in recurrent bacterial infections due to an inability to produce antibodies, rather than the severe combined T and B cell dysfunction seen in SCID.
*ZAP70*
- **ZAP70** deficiency is a cause of **SCID**. It leads to impaired T-cell receptor signaling, resulting in profound functional T-cell lymphopenia.
- Patients with ZAP70 deficiency have normal numbers of CD4 T cells but very low or absent CD8 T cells, and their T cells are functionally impaired, leading to severe immunodeficiency.
*IL2RG*
- The **IL2RG** gene encodes the common gamma chain (γc), a crucial component of several **interleukin receptors (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21)**. [1]
- Mutations in IL2RG cause **X-linked SCID (X-SCID)**, the most common form of SCID, leading to a block in T-cell and NK-cell development due to defective cytokine signaling. [1]
*JAK3*
- **Janus kinase 3 (JAK3)** is a tyrosine kinase that associates with the **common gamma chain (γc)** and is essential for cytokine signaling downstream of the γc-containing receptors. [1]
- **JAK3 deficiency** results in an **autosomal recessive form of SCID**, clinically indistinguishable from X-SCID, with impaired T-cell and NK-cell development due to defective cytokine signaling. [1]
**References:**
[1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 247-248.
JAK-STAT Signaling Pathway Indian Medical PG Question 2: Which of the following statements about the secondary immune response is false?
- A. The lag period is absent or significantly shorter.
- B. There is a negative phase in the response.
- C. Only T-dependent antigens are recognized.
- D. Immune response against a subsequent antigenic challenge is absent. (Correct Answer)
JAK-STAT Signaling Pathway Explanation: ***Immune response against a subsequent antigenic challenge is absent.***
- This statement is **false** because the secondary immune response is characterized by a **much stronger and faster** immune response upon subsequent exposure to the same antigen.
- The presence of **memory cells** ensures that the immune system is highly prepared to combat the antigen more efficiently than during the primary response.
*The lag period is absent or significantly shorter.*
- This statement is **true** for the secondary immune response. The **memory B and T cells** can be rapidly activated, reducing the time needed to mount an effective response.
- Unlike primary responses that can take 5-10 days to produce antibodies, secondary responses typically produce antibodies within **1-3 days**.
*There is a negative phase in the response.*
- This statement is **false** for the secondary immune response. The **negative phase** is characteristic of the **primary immune response**, not the secondary response.
- The negative phase in primary response refers to a transient drop in antibody concentration after initial antigen exposure due to antigen-antibody complex formation. However, the **secondary response shows immediate and robust antibody production** without this negative phase due to pre-existing memory cells.
- While this statement is technically false, the question asks for THE false statement, and Option D is more obviously and fundamentally false.
*Only T-dependent antigens are recognized.*
- This statement is **partially false** but has some truth in context. While **T-dependent antigens** generate the most robust secondary responses with strong memory cell formation, the immune system doesn't ONLY recognize T-dependent antigens.
- **T-independent antigens** can elicit responses but typically generate weaker, shorter-lived immunity without strong memory formation. The classical, robust secondary immune response with anamnestic features is predominantly associated with T-dependent antigens.
JAK-STAT Signaling Pathway Indian Medical PG Question 3: Which is TRUE about JAK2 V617F mutation?
- A. Seen in ET.
- B. Rare in CML.
- C. Common in PV but not specific.
- D. Seen in PV, ET, and PMF but rare in CML. (Correct Answer)
JAK-STAT Signaling Pathway Explanation: ***Seen in PV, ET, and PMF but rare in CML.***
- The **JAK2 V617F mutation** is a hallmark of classic Philadelphia chromosome-negative **myeloproliferative neoplasms (MPNs)**, including **polycythemia vera (PV)** (~95%), **essential thrombocythemia (ET)** (~50-60%), and **primary myelofibrosis (PMF)** (~50-60%) [1].
- It is **rare in chronic myeloid leukemia (CML)**, which is defined by the **BCR-ABL1 fusion gene** [1].
- This option provides the **most comprehensive and accurate** description of JAK2 V617F distribution across myeloproliferative disorders.
*Seen in ET.*
- While the **JAK2 V617F mutation** is indeed found in approximately 50-60% of patients with **essential thrombocythemia (ET)**, this statement is **incomplete** [2].
- It fails to mention the mutation's presence in other MPNs (PV and PMF) and its rarity in CML, making it a partial truth rather than the best answer.
*Rare in CML.*
- This statement is **medically accurate** - JAK2 V617F is indeed **rare in CML**, as CML is characterized by the **BCR-ABL1 translocation** [1].
- However, this option is **incomplete** as it omits crucial information about the mutation's presence in PV, ET, and PMF.
- Knowing where the mutation IS found is more clinically useful than only knowing where it's rare.
*Common in PV but not specific.*
- This statement is **technically correct** - the **JAK2 V617F mutation** is found in about 95% of patients with **polycythemia vera (PV)**, making it very **common** in this condition [2].
- The phrase "**not specific**" is also accurate because the mutation is found in other MPNs (ET and PMF), not exclusively in PV [1].
- However, this option is less complete than the correct answer because it doesn't describe the full distribution pattern across all major MPNs or mention its rarity in CML.
**References:**
[1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, p. 624.
[2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 614-615.
JAK-STAT Signaling Pathway Indian Medical PG Question 4: Knudson two-hit hypothesis is classically exemplified by
- A. Crohn disease
- B. Ulcerative colitis
- C. Retinoblastoma (Correct Answer)
- D. Melanoma
JAK-STAT Signaling Pathway Explanation: ***Retinoblastoma***
- The **Knudson two-hit hypothesis** was **originally formulated** based on studies of **retinoblastoma** by Alfred Knudson in 1971 [1].
- It posits that **two separate mutational events** are required to inactivate **both alleles** of the **Rb tumor suppressor gene** in the same cell, leading to tumor formation [1], [2].
- This explains both **hereditary** (germline mutation + somatic mutation) and **sporadic** (two somatic mutations) forms of retinoblastoma [1], [2].
- Retinoblastoma remains the **paradigmatic example** of this hypothesis and tumor suppressor gene inactivation [2].
*Crohn disease*
- This is an **inflammatory bowel disease**, not a neoplasm, with complex etiology involving genetic susceptibility, environmental factors, and immune dysregulation.
- Its pathogenesis does **not follow the Knudson two-hit hypothesis**, which specifically relates to tumor suppressor gene inactivation in cancer.
*Ulcerative colitis*
- Similar to Crohn disease, **ulcerative colitis** is an **inflammatory bowel disease** with multifactorial etiology, not a neoplastic condition.
- While chronic UC can increase colorectal cancer risk through accumulated mutations, the disease itself does **not represent the two-hit hypothesis model**.
*Melanoma*
- **Melanoma** is a skin cancer often linked to **UV radiation** and mutations in oncogenes like **BRAF** and tumor suppressors like **PTEN** and **CDKN2A**. [3]
- While some familial melanomas involve tumor suppressor genes, melanoma is **not the classic example** used to illustrate the Knudson hypothesis—**retinoblastoma holds that distinction**.
**References:**
[1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, p. 300.
[2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 227-228.
[3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 297-298.
JAK-STAT Signaling Pathway Indian Medical PG Question 5: All the following hormones have receptors on the plasma membrane of target tissues except:
- A. Epinephrine
- B. Glucagon
- C. Estradiol (Correct Answer)
- D. Thyrotropin
JAK-STAT Signaling Pathway Explanation: ***Estradiol***
- **Estradiol** is a **steroid hormone** derived from cholesterol, making it **lipid-soluble**.
- Due to its lipid solubility, estradiol can readily pass through the **plasma membrane** and bind to **intracellular receptors** in the cytoplasm or nucleus.
*Epinephrine*
- **Epinephrine** is a **catecholamine hormone** and is **water-soluble**.
- Water-soluble hormones cannot cross the lipid bilayer of the plasma membrane and thus bind to **receptors located on the cell surface**.
*Glucagon*
- **Glucagon** is a **peptide hormone** and is **water-soluble**.
- Like other peptide hormones, it binds to **specific receptors embedded in the plasma membrane** to elicit its cellular effects via second messenger systems.
*Thyrotropin*
- **Thyrotropin**, also known as **Thyroid-Stimulating Hormone (TSH)**, is a **glycoprotein hormone** and is **water-soluble**.
- TSH exerts its action by binding to **receptors on the plasma membrane** of thyroid follicular cells.
JAK-STAT Signaling Pathway Indian Medical PG Question 6: In the mitogen activated protein kinase pathway, the activation of RAS is counteracted by
- A. Inositol triphosphate
- B. GTPase activating protein (Correct Answer)
- C. Phosphatidyl inositol
- D. Protein kinase C
JAK-STAT Signaling Pathway Explanation: ***GTPase activating protein***
- **GTPase Activating Proteins (GAPs)** facilitate the hydrolysis of **GTP bound to RAS** to GDP, converting active RAS back to its inactive state.
- This inactivation is crucial for turning off the downstream signaling of the **MAPK pathway** and preventing uncontrolled cell proliferation.
*Inositol triphosphate*
- **Inositol triphosphate (IP3)** is a secondary messenger that triggers the release of **intracellular calcium** from the endoplasmic reticulum.
- It is involved in various signaling pathways, but its primary role is not to directly counteract RAS activation.
*Phosphatidyl inositol*
- **Phosphatidylinositol (PI)** is a component of cell membranes and can be phosphorylated to produce various **phosphatidylinositol phosphates (PIPs)**, like **PIP2** and **PIP3**.
- These molecules act as docking sites for signaling proteins but do not directly inactivate RAS.
*Protein kinase C*
- **Protein kinase C (PKC)** is a family of enzymes involved in signal transduction, typically activated by **diacylglycerol (DAG)** and calcium.
- It phosphorylates various proteins, mediating diverse cellular responses, but it does not directly counteract the activation of RAS.
JAK-STAT Signaling Pathway Indian Medical PG Question 7: JAK-STAT pathway is seen in which of the following?
- A. Calcitonin
- B. Aldosterone
- C. Vasopressin
- D. Leptin (Correct Answer)
JAK-STAT Signaling Pathway Explanation: ***Leptin***
- **Leptin** binding to its receptor activates the **JAK-STAT pathway**, regulating appetite and metabolism.
- This pathway involves the phosphorylation of **STAT proteins**, which then translocate to the nucleus to induce gene expression.
*Calcitonin*
- **Calcitonin** activates **G protein-coupled receptors**, leading to an increase in intracellular cyclic AMP (cAMP).
- Its primary role is in **calcium homeostasis**, lowering blood calcium levels.
*Aldosterone*
- **Aldosterone** is a steroid hormone that binds to **intracellular mineralocorticoid receptors**.
- This complex then acts as a **transcription factor**, affecting gene expression in the kidneys to regulate sodium and potassium balance.
*Vasopressin*
- **Vasopressin** (ADH) binds to **G protein-coupled receptors** (V1 and V2 receptors).
- V2 receptor activation in the kidney leads to increased **cAMP** and insertion of aquaporins, regulating water reabsorption.
JAK-STAT Signaling Pathway Indian Medical PG Question 8: Select the correct sequence of events in the cAMP signaling pathway.
- A. Adenylyl cyclase converts ATP to cAMP, which activates PKA. (Correct Answer)
- B. PKA is activated before cAMP is formed.
- C. Adenylyl cyclase activates PKA before producing cAMP.
- D. cAMP directly activates adenylyl cyclase to produce more cAMP.
JAK-STAT Signaling Pathway Explanation: ***Adenylyl cyclase converts ATP to cAMP, which activates PKA.***
- **Adenylyl cyclase** is an enzyme that catalyzes the conversion of **ATP (adenosine triphosphate)** into **cyclic AMP (cAMP)**, a crucial second messenger.
- Subsequently, **cAMP** binds to and activates **Protein Kinase A (PKA)**, which then phosphorylates various target proteins to mediate cellular responses.
*PKA is activated before cAMP is formed.*
- **cAMP formation** is a prerequisite for **PKA activation**; PKA cannot be activated independently before cAMP is produced.
- The binding of **cAMP** to the regulatory subunits of **PKA** is what causes the dissociation and activation of its catalytic subunits.
*Adenylyl cyclase activates PKA before producing cAMP.*
- **Adenylyl cyclase's** sole function in this pathway is to synthesize **cAMP** from ATP; it does not directly activate PKA.
- **PKA activation** is mediated by **cAMP**, not directly by adenylyl cyclase.
*cAMP directly activates adenylyl cyclase to produce more cAMP.*
- While **cAMP** is a critical messenger, it does not directly activate **adenylyl cyclase** to produce more of itself in a positive feedback loop.
- **Adenylyl cyclase** is typically activated by **G-protein coupled receptors (GPCRs)** binding to their ligands, which then stimulate G proteins to activate adenylyl cyclase.
JAK-STAT Signaling Pathway Indian Medical PG Question 9: Phospholipid associated with the mechanism of hormone action is
- A. Phosphatidylcholine
- B. Phosphatidylethanolamine
- C. Plasmalogen
- D. Phosphatidylinositol (Correct Answer)
JAK-STAT Signaling Pathway Explanation: ***Phosphatidylinositol*** (Correct)
- **Phosphatidylinositol (PI)** and its phosphorylated derivatives, particularly **PIP2 (phosphatidylinositol 4,5-bisphosphate)**, are critical in signal transduction pathways activated by many hormones.
- Hormones binding to **G protein-coupled receptors** can activate phospholipase C, which cleaves PIP2 into **inositol triphosphate (IP3)** and **diacylglycerol (DAG)**, leading to increased intracellular calcium and protein kinase C activation, respectively.
*Phosphatidylcholine* (Incorrect)
- **Phosphatidylcholine** is a major component of cell membranes and is involved in membrane structure and fluidity.
- While it can be a source of signaling molecules like **lysophosphatidic acid**, it is not primarily associated with the initial intracellular signaling events of hormone action in the same way as phosphatidylinositol.
*Phosphatidylethanolamine* (Incorrect)
- **Phosphatidylethanolamine** is another abundant membrane phospholipid primarily involved in membrane structure and stability.
- It can be a precursor for other lipids, but it does not directly participate in the **second messenger systems** triggered by most hormones as a primary signaling molecule.
*Plasmalogen* (Incorrect)
- **Plasmalogens** are a unique class of phospholipids containing an ether bond at the sn-1 position.
- They are abundant in certain tissues, particularly nervous and cardiovascular tissues, and are thought to have antioxidant properties, but they are not directly involved in the initiating events of **hormone signaling pathways**.
JAK-STAT Signaling Pathway Indian Medical PG Question 10: What is the primary function of G-proteins in cellular signaling?
- A. Signal transducers (Correct Answer)
- B. Mediators of hormone action
- C. Molecules that bind hormones
- D. Intracellular signaling molecules
JAK-STAT Signaling Pathway Explanation: ***Signal transducers***
- G-proteins act as **molecular switches**, converting extracellular signals received by G protein-coupled receptors (GPCRs) into intracellular responses.
- They bind **GTP** in their active state and **hydrolyze it to GDP** to become inactive, regulating downstream effectors like enzymes and ion channels.
*Mediators of hormone action*
- While G-proteins are involved in the action of many hormones, this describes a *result* of their function rather than their fundamental role.
- Their primary function is to transduce signals, which then mediates hormone effects.
*Molecules that bind hormones*
- **Receptors**, not G-proteins, are primarily responsible for binding hormones or other ligands.
- G-proteins are activated *after* a receptor binds a ligand and undergoes a conformational change.
*Intracellular signaling molecules*
- This statement is true, but it's a broad category. **Signal transducers** specifically highlights their role in converting one form of signal to another.
- Many molecules operate intracellularly, but G-proteins' unique role is in linking receptor activation to effector modulation.
More JAK-STAT Signaling Pathway Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
